divendres, 28 de març del 2014

Axonics raises $33M for its neuromodulation tech




Alfred Mann Foundation spinout Axonics Modulation Technologies raises nearly $33 million in a Series A round for its neuromodulation technology.





Axonics raises $33M for its neuromodulation tech

Axonics Modulation Technologies said it drummed up a $32.6 million Series A round for the neuromodulation technology it's developing to treat chronic pain and overactive bladder.


Irvine, Calif.-based Axonics said the round was led by Edmond de Rothschild Investment Partners and included NeoMed Management, Legend Capital and "a select group of private individuals."




read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1ftEUiK

Cap comentari:

Publica un comentari a l'entrada